Control Bionics Limited (ASX:CBL) insider Lindsay Phillips bought 71,991 shares of the business’s stock in a transaction that occurred on Monday, September 20th. The stock was bought at an average price of A$0.65 ($0.46) per share, with a total value of A$46,650.17 ($33,321.55).
About Control Bionics
Control Bionics Limited designs, manufactures, and sells wireless wearable electromyography based augmentative and alternative communication technologies that allow users to operate and communicate through a computer using their thoughts and neuroelectric signals. It offers Eye Control Duo, an integrated eye tracking device for those living with paralysis and loss of speech; NeuroNode Trilogy, a solution for those living with paralysis and loss of speech; and Control Bionics Complete Communication System, an out of the box solution for those living with paralysis and loss of speech.
Read More: What is Cost of Capital?
Receive News & Ratings for Control Bionics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Control Bionics and related companies with MarketBeat.com's FREE daily email newsletter.